METABOLIX, INC. (NASDAQ:MBLX) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard: Transfer of Listing.>
METABOLIX, INC. (NASDAQ:MBLX) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
On December 28, 2016, Metabolix, Inc. (the “Company”) received notice that The Nasdaq Stock Market LLC (“Nasdaq”) has granted the Company an additional 180 days (until June 26, 2017) to regain compliance with Nasdaq’s $1.00 per share minimum bid price requirement under Nasdaq Marketplace Listing Rule 5810(c)(3)(A). Previously, on June 30, 2016, Nasdaq notified the Company that it did not meet the minimum bid price requirement required for continued listing on The Nasdaq Capital Market, and the Company was given until December 27, 2016 to achieve compliance.
The Company may achieve compliance during this additional 180-day period if the closing bid price of the Company’s common stock is at least $1.00 per share for a minimum of 10 consecutive business days by June 26, 2017. If the Company fails to regain compliance on or prior to June 26, 2017, the Company’s stock will be subject to delisting by Nasdaq. The Company is considering actions that it may take in order to regain compliance with this continued listing requirement.
About METABOLIX, INC. (NASDAQ:MBLX)
Metabolix, Inc. is an advanced biomaterials company. The Company operates through the business of developing and commercializing technologies for the production of polymers and chemicals in microbes and plants segment. The Company is focused on delivering solutions to the plastics industry. The Company has its operations in the microbial genetics, fermentation process engineering, chemical engineering, polymer science, plant genetics and botanical science. The Company is focused on a family of biopolymers found in nature called polyhydroxyalkanoates (PHAs), which occur naturally in living organisms and are chemically similar to polyesters. The Company is also focusing on applications where the performance, biodegradability, biocontent and other attributes of its PHA biopolymers provide functional advantages, such as biodegradation, required by such applications, including PHA resins for molded articles and films, as well as PHA latex and other PHA coatings for paper and cardboard. METABOLIX, INC. (NASDAQ:MBLX) Recent Trading Information
METABOLIX, INC. (NASDAQ:MBLX) closed its last trading session up +0.012 at 0.363 with 69,502 shares trading hands.
Metabolix, Inc. is an advanced biomaterials company. The Company operates through the business of developing and commercializing technologies for the production of polymers and chemicals in microbes and plants segment. The Company is focused on delivering solutions to the plastics industry. The Company has its operations in the microbial genetics, fermentation process engineering, chemical engineering, polymer science, plant genetics and botanical science. The Company is focused on a family of biopolymers found in nature called polyhydroxyalkanoates (PHAs), which occur naturally in living organisms and are chemically similar to polyesters. The Company is also focusing on applications where the performance, biodegradability, biocontent and other attributes of its PHA biopolymers provide functional advantages, such as biodegradation, required by such applications, including PHA resins for molded articles and films, as well as PHA latex and other PHA coatings for paper and cardboard. METABOLIX, INC. (NASDAQ:MBLX) Recent Trading Information
METABOLIX, INC. (NASDAQ:MBLX) closed its last trading session up +0.012 at 0.363 with 69,502 shares trading hands.
